Early research (Phase 1)UnknownNCT04830579
What this trial is testing
Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions
Who this might be right for
Bioequivalence
Pharmtechnology LLC 34